,title,source,link,date
0,AstraZeneca Pharma India's (NSE:ASTRAZEN) 17% CAGR outpaced the company's earnings growth over the same five-year period,Simply Wall St,news.google.com/articles/CBMipgFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL2luL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25zZS1hc3RyYXplbi9hc3RyYXplbmVjYS1waGFybWEtaW5kaWEtc2hhcmVzL25ld3MvYXN0cmF6ZW5lY2EtcGhhcm1hLWluZGlhcy1uc2Vhc3RyYXplbi0xNy1jYWdyLW91dHBhY2VkLXRoZS1j0gGqAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvaW4vcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnNlLWFzdHJhemVuL2FzdHJhemVuZWNhLXBoYXJtYS1pbmRpYS1zaGFyZXMvbmV3cy9hc3RyYXplbmVjYS1waGFybWEtaW5kaWFzLW5zZWFzdHJhemVuLTE3LWNhZ3Itb3V0cGFjZWQtdGhlLWMvYW1w?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-17
